-
Something wrong with this record ?
Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells
K. Smolková, A. Dvořák, J. Zelenka, L. Vítek, P. Ježek,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Glutarates metabolism MeSH
- Cell Hypoxia physiology MeSH
- Isocitrate Dehydrogenase genetics metabolism MeSH
- Oxygen metabolism MeSH
- Humans MeSH
- Biomarkers, Tumor genetics metabolism MeSH
- Cell Line, Tumor MeSH
- Breast Neoplasms enzymology genetics metabolism MeSH
- Partial Pressure MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Mitochondrial NADPH-dependent isocitrate dehydrogenase, IDH2, and cytosolic IDH1, catalyze reductive carboxylation of 2-oxoglutarate. Both idh2 and idh1 monoallelic mutations are harbored in grade 2/3 gliomas, secondary glioblastomas and acute myeloid leukemia. Mutant IDH1/IDH2 enzymes were reported to form an oncometabolite r-2-hydroxyglutarate (2HG), further strengthening malignancy. We quantified CO2-dependent reductive carboxylation glutaminolysis (RCG) and CO2-independent 2HG production in HTB-126 and MDA-MB-231 breast carcinoma cells by measuring (13)C incorporation from 1-(13)C-glutamine into citrate, malate, and 2HG. For HTB-126 cells, (13)C-citrate, (13)C-malate, and (13)C-2-hydroxyglutarate were enriched by 2-, 5-, and 15-fold at 5mM glucose (2-, 2.5-, and 13-fold at 25 mM glucose), respectively, after 6 h. Such enrichment decreased by 6% with IDH1 silencing, but by 30-50% upon IDH2 silencing while cell respiration and ATP levels rose up to 150%. Unlike 2HG production RCG declined at decreasing CO2. At hypoxia (5% O2), IDH2-related and unrelated (13)C-accumulation into citrate and malate increased 1.5-2.5-fold with unchanged IDH2 expression; whereas hypoxic 2HG formation did not. (13)C-2HG originated by ∼50% from other than IDH2 or IDH1 reactions, substantiating remaining activity in IDH1&2-silenced cells. Relatively high basal (12)C-2HG levels existed (5-fold higher vs. non-tumor HTB-125 cells) and (13)C-2HG was formed despite the absence of any idh2 and idh1 mutations in HTB-126 cells. Since RCG is enhanced at hypoxia (frequent in solid tumors) and 2HG can be formed without idh1/2 mutations, we suggest 2HG as an analytic marker (in serum, urine, or biopsies) predicting malignancy of breast cancer in all patients.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020753
- 003
- CZ-PrNML
- 005
- 20160805120922.0
- 007
- ta
- 008
- 160722s2015 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biocel.2015.05.012 $2 doi
- 024 7_
- $a 10.1016/j.biocel.2015.05.012 $2 doi
- 035 __
- $a (PubMed)26007236
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Smolková, Katarína $u Department of Membrane Transport Biophysics, No.75, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. Electronic address: smolkova@biomed.cas.cz.
- 245 10
- $a Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells / $c K. Smolková, A. Dvořák, J. Zelenka, L. Vítek, P. Ježek,
- 520 9_
- $a Mitochondrial NADPH-dependent isocitrate dehydrogenase, IDH2, and cytosolic IDH1, catalyze reductive carboxylation of 2-oxoglutarate. Both idh2 and idh1 monoallelic mutations are harbored in grade 2/3 gliomas, secondary glioblastomas and acute myeloid leukemia. Mutant IDH1/IDH2 enzymes were reported to form an oncometabolite r-2-hydroxyglutarate (2HG), further strengthening malignancy. We quantified CO2-dependent reductive carboxylation glutaminolysis (RCG) and CO2-independent 2HG production in HTB-126 and MDA-MB-231 breast carcinoma cells by measuring (13)C incorporation from 1-(13)C-glutamine into citrate, malate, and 2HG. For HTB-126 cells, (13)C-citrate, (13)C-malate, and (13)C-2-hydroxyglutarate were enriched by 2-, 5-, and 15-fold at 5mM glucose (2-, 2.5-, and 13-fold at 25 mM glucose), respectively, after 6 h. Such enrichment decreased by 6% with IDH1 silencing, but by 30-50% upon IDH2 silencing while cell respiration and ATP levels rose up to 150%. Unlike 2HG production RCG declined at decreasing CO2. At hypoxia (5% O2), IDH2-related and unrelated (13)C-accumulation into citrate and malate increased 1.5-2.5-fold with unchanged IDH2 expression; whereas hypoxic 2HG formation did not. (13)C-2HG originated by ∼50% from other than IDH2 or IDH1 reactions, substantiating remaining activity in IDH1&2-silenced cells. Relatively high basal (12)C-2HG levels existed (5-fold higher vs. non-tumor HTB-125 cells) and (13)C-2HG was formed despite the absence of any idh2 and idh1 mutations in HTB-126 cells. Since RCG is enhanced at hypoxia (frequent in solid tumors) and 2HG can be formed without idh1/2 mutations, we suggest 2HG as an analytic marker (in serum, urine, or biopsies) predicting malignancy of breast cancer in all patients.
- 650 _2
- $a nádorové biomarkery $x genetika $x metabolismus $7 D014408
- 650 _2
- $a nádory prsu $x enzymologie $x genetika $x metabolismus $7 D001943
- 650 _2
- $a hypoxie buňky $x fyziologie $7 D015687
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glutaráty $x metabolismus $7 D005977
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a isocitrátdehydrogenasa $x genetika $x metabolismus $7 D007521
- 650 _2
- $a kyslík $x metabolismus $7 D010100
- 650 _2
- $a parciální tlak $7 D010313
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dvořák, Aleš $u Department of Membrane Transport Biophysics, No.75, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Institute of Medical Biochemistry and Laboratory Diagnostics, Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Electronic address: ales.dvorak@biomed.cas.cz.
- 700 1_
- $a Zelenka, Jaroslav $u Department of Membrane Transport Biophysics, No.75, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. Electronic address: zelenka@biomed.cas.cz.
- 700 1_
- $a Vítek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Electronic address: vitek@cesnet.cz.
- 700 1_
- $a Ježek, Petr $u Department of Membrane Transport Biophysics, No.75, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. Electronic address: jezek@biomed.cas.cz.
- 773 0_
- $w MED00006475 $t The international journal of biochemistry & cell biology $x 1878-5875 $g Roč. 65, č. - (2015), s. 125-33
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26007236 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160805121155 $b ABA008
- 999 __
- $a ok $b bmc $g 1155423 $s 945281
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 65 $c - $d 125-33 $e 20150522 $i 1878-5875 $m International journal of biochemistry and cell biology $n Int J Biochem Cell Biol $x MED00006475
- LZP __
- $a Pubmed-20160722